全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 2408294-08-4 | Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II) | C39H49FeNO3P2PdS |
| 2408495-96-3 | Budesonide 21-Butyrate Impurity;[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] butanoate | C29H40O7 |
| 2408968-92-1 | (1-(Aminomethyl)-2-oxabicyclo[3.1.1]heptan-5-yl)methanol hydrochloride | C8H16ClNO2 |
| 2409005-96-3 | 3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(6-bromo-5-fluoro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H10BrFN2O3 |
| 2409479-29-2 | (R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;BAY-985 | C27H30F3N9O |
| 2409562-95-2 | 1-Bromo-5-(tert-butyl)-2,3-dichlorobenzene | C10H11BrCl2 |
| 2410075-48-6 | 7-Ketoabiraterone acetate;[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-pyridin-3-yl-1,2,3,4,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-yl] acetate | C26H31NO3 |
| 2410284-90-9 | Nintedanib Impurity 33;Dimethyl 3,3'-(((((2,2'-(piperazine-1,4-diyl)bis(acetyl))bis(methylazanediyl))bis(4,1-phenylene))bis(azanediyl))bis(phenylmethanylylidene))(3Z,3'E)-bis(2-oxoindoline-6-carboxylate) | C56H52N8O8 |
| 2410401-58-8 | N-(Dibenzo[b,d]furan-3-yl)-9-phenyl-9H-carbazol-2-amine | C30H20N2O |
| 2413185-88-1 | Oseltamivir Impurity 13;Ethyl (1S,5S,6S)-5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | C14H22O4 |
| 2414245-11-5 | (E,3S,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate calcium | C44H54CaF2N6O12S2 |
| 2414962-06-2 | Amlodipine EP Impurity D HCl;3-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate hydrochloride | C20H24Cl2N2O5 |
| 2415937-32-3 | 4-Iodobenzoyl fluoride | C7H4FIO |
| 2416949-69-2 | Linagliptin Impurity 7;(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide | C25H29N7O4 |
| 2421187-79-1 | N6-((2-(3-Methyl-3H-diazirin-3-yl)ethoxy)carbonyl)-L-lysine hydrochloride | C11H21ClN4O4 |
| 2434841-21-9 | (trans-4-(4-Amino-3-(difluoromethyl)-1H-pyrazol-1-yl)cyclohexyl)methanol;[4-[4-amino-3-(difluoromethyl)pyrazol-1-yl]cyclohexyl]methanol | C11H17F2N3O |
| 2434843-97-5 | 5-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid;5-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | C12H12N4O3 |
| 2436760-81-3 | Befiradol hydrochloride;(3-chloro-4-fluorophenyl)-[4-fluoro-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]methanone;hydrochloride | C20H23Cl2F2N3O |
| 2436762-89-7 | 8-Bromo-1,7-di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione;Linagliptin Impurity 55;1H-Purine-2,6-dione, 8-bromo-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl | C14H13BrN4O2 |
| 2439164-91-5 | cabozantinibimpurity16;1-N,1-N'-bis[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]cyclopropane-1,1-dicarboxamide | C39H34N4O8 |
| 2446474-09-3 | Pomalidomide-PEG3-Amine HCl salt;4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;hydrochloride | C21H29ClN4O7 |
| 2446799-72-8 | Linagliptin Impurity 64;(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one | C25H28N8O2 |
| 2448346-01-6 | Cinacalcet impurity 23;(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propanamide | C22H23NO |
| 2452301-09-4 | Empagliflozin Methyl Acetate;((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate | C25H29ClO8 |
| 2454396-80-4 | 2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine | C7HCl3FN3 |
| 2454397-74-9 | Ethyl 4-amino-6-chloro-5-fluoronicotinate | C8H8ClFN2O2 |
| 2454397-75-0 | 7-Chloro-8-fluoropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | C7H3ClFN3O2 |
| 2454397-84-1 | 2-(8-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C16H18BClO2 |
| 2454490-66-3 | ((2R,7aR)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol | C8H14FNO |
| 2457316-06-0 | Indapamide Impurity 11;2-Chloro-5-(2-methylindoline-1-carbonyl)benzenesulfonamide | C16H15ClN2O3S |
| 2458234-37-0 | Palbociclib Impurity 21;8-cyclopentyl-5-methyl-2,6-bis((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | C31H39N11O |
| 2459974-80-0 | Terbutaline Impurity 21 HBr;5-(2-(tert-butylamino)ethyl)benzene-1,3-diol, hydrobromide (1:1) | C12H19NO2 .HBr |
| 2460255-81-4 | Benzyl {3-[(1R,3S)-3-hydroxycyclopentyl]-1-(2-methyl-2-propanyl)-1H-pyrazol-5-yl}carbamate | C20H27N3O3 |
| 2460751-66-8 | Fmoc-L-lys[C20-otbu-glu(otbu)-aeea-aeea]-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4R)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoic acid | C66H105N5O16 |
| 2468780-76-7 | 3-(5-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(6-fluoro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H11FN2O3 |
| 2470130-12-0 | Sulfamethizole-d4;4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzene-d4-sulfonamide | C9H6D4N4O2S2 |
| 2477812-42-1 | N-Ethyl-2-(4-formylphenyl)acetamide | C11H13NO2 |
| 2484719-11-9 | Alpha-Epoxyabiraterone Acetate;17-(Pyridin-3-yl)-16a,17a-epoxyandrost-5-en-3ß-yl acetate | C26H33NO3 |
| 2484719-14-2 | Abiraterone Ethyl Ether;3-[(3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine | C26H35NO |
| 2484719-15-3 | Abiraterone Isopropyl Ether;3-[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-propan-2-yloxy-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine | C27H37NO |
| 2484719-16-4 | 3-Deoxy 3-Chloro Abiraterone;3-[(3S,8R,9S,10R,13S,14S)-3-chloro-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pyridine | C24H30ClN |
| 2489747-26-2 | Mirabegron Impurity 2;(R)-2-(2-Aminothiazol-4-yl)-N-(4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)amino)-2-oxoethyl)thiazol-2-yl)acetamide | C26H28N6O3S2 |
| 2492423-29-5 | EIDD-2801;[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate | C13H19N3O7 |
| 2499663-01-1 | Stm2457;N-[[6-[(cyclohexylmethylamino)methyl]imidazo[1,2-a]pyridin-2-yl]methyl]-4-oxopyrido[1,2-a]pyrimidine-2-carboxamide | C25H28N6O2 |
| 2503325-78-6 | (R)-4,4-Difluoro-3-methylpiperidine hydrochloride | C6H12ClF2N |
| 2504915-16-4 | Tert-butyl 4-(3-formyl-4-(methoxycarbonyl)phenyl)piperazine-1-carboxylate | C18H24N2O5 |
| 2512190-67-7 | Vigabatrin Impurity 2;6-(2-ethenyl-5-oxopyrrolidin-1-yl)-4-oxohexanoic acid | C12H17NO4 |
| 2514682-10-9 | Mesalazine (Mesalamine) EP Impurity J DiHCl;3,5-diamino-2-hydroxybenzoic acid, hydrochloride (1:2) | C7H8N2O3 .2HCl |
| 2514947-17-0 | Formoterol Impurity H;N-(5-((1R)-2-(Benzyl((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)-1-hydroxyethyl)-2-hydroxyphenyl)formamide | C26H30N2O4 |
| 2514961-29-4 | N-(4-(4-Acetamido-2-hydroxyphenoxy)phenyl)acetamide | C16H16N2O4 |